Among the subtypes of breast cancer, TNBC is the most aggressive, lacks the expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2), and accounts for 12–18% of all cases of breast cancer [5,6]. This evidence concerns the gene ERBB2 and breast cancer.